Godoy MHS, Ulloa-Aguirre A, Falcón MJC, Marsai MEE, Rivas LR, García-Lascurain LC

Language: Spanish
References: 11
Page: 1-7
PDF size: 758.12 Kb.

ABSTRACT

Background: antimulleriana hormone is a useful parameter for assessing ovarian reserve and response to ovulation induction in assisted reproduction.
Objective: To evaluate the relationship between serum antimulleriana hormone, follicle stimulating hormone, and number of antral follicles in the early follicular phase with the number of retrieved oocytes.
Material and Methods: This prospective study included 39 women aged 20 to 45 years old, attending the Reproductive Medicine Unit of the hospital for IVF treatment between November 1, 2010 and June 30, 2011. Concentrations were determined antimulleriana hormone and follicle stimulating hormone and the number of antral follicles in the early follicular phase. The concentrations were compared and correlated with the type of response to hyperstimulation (normo, hypo or hyper), by ANOVA, multiple comparison tests and Pearson correlations or Spearman.
Results: 25.6% of patients were hiporrespondedoras, 51.2% and 23% hiperrespondedoras normorrespondedoras. There was a positive linear correlation between the hormone antimulleriana, oocytes and hormone antimulleriana captured and the number of antral follicles. There were negative linear correlation between antimulleriana hormone and follicle stimulating hormone. There was no correlation between hormone levels and age antimulleriana. Hormone concentrations antimulleriana & 0.9 ng/mL were associated with normo-or hyper-responsiveness to ovarian stimulation.
Conclusions: In assessing the relationship between serum antimulleriana hormone, follicle stimulating hormone and the number of antral follicles is concluded that the hormone antimulleriana is an excellent marker of ovarian response in women subjected to hyperstimulation protocols. A value of 20.9 antimulleriana hormone predicts ovarian response adequate in terms of number of retrieved oocytes.

REFERENCES

1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Updat 2006;12:685-718.

2. Muttukrishna S, McGarrigle H, Wakim R, Khadum I, et al. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 2005;112:1384-1390.

3. Eldar-Geva T, Ben-Chetrit A, Spitz IM, Rabinowitz R, et al. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005;20:3178-3183.

4. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 2002;124:601-609.

5. De Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357-362.

6. Riggs RM, Duran EH, Baker MW, Kimble TD, et al. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-müllerian hormone, folliclestimulating hormone, inhibin B, and age. Am J Obstet Gynecol 2008;199:202.e1-8.

7. Singer T, Barad DH, Weghofer A, Gleicher N. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Fertil Steril 2009;91:2616-2619.

8. Arbo E, Vetori DV, Jiménez MF, Freitas FM, et al. Serum anti- Mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills. Hum Reprod 2007;22:3192-3196.

9. Mohamed KA, Davies WA. Antimüllerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate. Fertil Steril 2006;86:1515-1517.

10. Streuli I, Fraisse T, Pillet C, Ibecheole V, et al. Serum Antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids. Fertil Steril 2008;90:395-400.

11. La Marca A, Broekmans FJ, Volpe A, Fauser BC, Macklon NS; on behalf of the ESHRE Special Interest Group for Reproductive Endocrinology AMH Round Table. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 2009;Jun11.